The Timberwolves enter the second half of their season this week. Here's five important questions that face them in the remaining 41 games.
1. So what's the deal with Brandon Roy?
It has been an awfully quiet month since the Wolves announced Roy is pursuing a last-gasp alternative-treatment plan for his degenerative knees. That announcement came just hours after the Target Center media room was arranged for a news conference that never occurred.
One last hope to get himself healthy enough to play again, right?
Maybe not. Maybe this alternative treatment is simply a way to bide time and keep Roy and his $5 million salary slot on the roster in case the Wolves need his contract to swing a substantial deal by the Feb. 21 trade deadline.
As soon as he retires, that salary slot goes away.
2. The Wolves will re-sign both Mickael Gelabale and Chris Johnson for the rest of the season, won't they?
They almost certainly will, but they will have to make a roster move to do so.